LONDON--Edwards Lifesciences (NYSE: EW) today announced one-year data highlighting the continued outstanding performance of its SAPIEN 3 Ultra RESILIA valve. The data were presented at PCR London ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Analyst Josh Jennings from TD Cowen maintained a Hold rating on Edwards Lifesciences (EW – Research Report) and keeping the price target at ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Half of the study’s participants received the physician’s choice of either Edwards Lifesciences’ Sapien 3 or Medtronic’s Evolut family. The trial was the largest to date of Acurate neo2 ...

Hellboy: The demon with a stone for a hand and an obsession with cats, saves the world over and over. Here are our favorite ...

The randomized cohort included 901 people assigned either upfront TAVR (with the balloon-expandable Sapien 3 or Sapien 3 Ultra systems) or standard care with clinical surveillance. Investigators ...

U.S. Recession Signal Flares From 10-Year and 3-Month Yield Spread Sapien, a startup that incentivizes people to supply all sorts of data for use in AI, has raised $10.5 million in seed funding ...